2 stories
Qiagen N.V. is betting that drug discovery agents need a trustworthy knowledge foundation as much as capable models. For biopharma companies, that means giving agents information with clear provenance and enough context to support their answers.
Knowledge graphs are moving to the center of autonomous software development as enterprises push coding agents beyond quick fixes and into large, interconnected codebases. The more code an agent touches, the more it needs to know about everything that code connects to.
Showing 2 of 2 stories
You're all caught up.
Get the top AI news and tools straight to your inbox every week.
Weekly · AI news
Join 15,000+ AI enthusiasts
